Climb Bio, Inc. (CLYM) insider trading
Over the last 12 months, 1 insider bought $780K and 2 insiders sold $2.65M of Climb Bio, Inc. stock on the open market, according to SEC Form 4 filings.
Latest insider buys and sells
- Sep 15, 2026: Thomas Stephen Basil sold 100,000 shares ($1.37M)
- Jun 29, 2026: Brennan Aoife sold 30,902 shares ($407K)
- Feb 26, 2026: Thomas Stephen Basil sold 50,000 shares ($350K)
- Feb 13, 2026: Thomas Stephen Basil sold 100,000 shares ($529K)
- Jan 5, 2026: RA Capital Healthcare Fund LP bought 7,111 shares ($24.9K)
- Dec 12, 2025: RA Capital Healthcare Fund LP bought 314,561 shares ($755K)
- Jun 30, 2025: Brennan Aoife sold 20,618 shares ($25.2K)
- Jun 20, 2025: Pimblett Emily sold 1,242 shares ($1.54K)
- Mar 20, 2025: Pimblett Emily sold 1,199 shares ($1.57K)
- Dec 19, 2024: Pimblett Emily sold 1,235 shares ($2.50K)